Lung stem cells: therapeutic prospects

H. Rippon (Omaha, United States Of America)

Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes
Number: 10

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Rippon (Omaha, United States Of America). Lung stem cells: therapeutic prospects. Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Stem cells and lung cancer treatment: any hope?
Source: International Congress 2016 – Molecular footprints in lung cancer diagnosis and management
Year: 2016


Lung organoids: powerful tools for studying lung stem cells and diseases
Source: Eur Respir Monogr 2021; 91: 175-189
Year: 2021


Oral Presentation: Lung stem cells and their niche
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012

Stem cells, lung pathogenesis and therapeutic potential
Source: Annual Congress 2005 - Scientific year in review
Year: 2005

Lung stem cells and the role of the stem cell niche
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019


Bone marrow-derived mesenchymal stem cells involve in lymphangiogenesis of lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Lung stem cells and lung cancer
Source: ERS Lung Science Conference 2017
Year: 2017

Potential effects of the mechanical microenvironment in lung bioengineering with stem cells
Source: Research Seminar 2014 - The many faces of stem cells in respiratory diseases
Year: 2014


Embryonic stem cells as source for endothelial cells for cell-based therapies
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010

Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015



Evaluation of pulmonary functions after hematopoietic stem cell transplantation in children
Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma
Year: 2015

Lung function improvement after hematopoetic stem cell transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 173s
Year: 2007

Lung transplantation after allogeneic stem cell transplantation: a pan-European experience
Source: Eur Respir J, 51 (2) 1701330; 10.1183/13993003.01330-2017
Year: 2018



Intratracheal application of healthy lung derived Mesenchymal Stem Cells (DON-MSC) in the form of biospheres (BS) as potential therapeutic agents for chronic lung disease
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020

Identification and characterization of mesenchymal stem cells in the human lung
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Update on lung transplantation: programmes, patients and prospects
Source: Eur Respir Rev 2012 21: 271-305
Year: 2012